Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis (Q36337187)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

2 August 2019

0 references

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

atrial fibrillation

5 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

2 August 2019

5 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

2 August 2019

1 reference

2 August 2019

5

object named as

Gary Tse

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

8

object named as

Guangping Li

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Panagiotis Korantzopoulos

3

object named as

Panagiotis Korantzopoulos

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Zhiwei Zhang

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Xiaowei Zhang

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Konstantinos P Letsas

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mengqi Gong

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Lei Meng

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tong Liu

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 April 2017

6 references

Europe PubMed Central

PMC publication ID

13 August 2017

14 March 2019

22 March 2019

24 March 2019

17 June 2019

2 August 2019

BMC Cardiovascular Disorders

6 references

Europe PubMed Central

PMC publication ID

13 August 2017

14 March 2019

22 March 2019

24 March 2019

17 June 2019

2 August 2019

17

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

96

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

copyright license

Creative Commons Attribution 4.0 International

5 references

Europe PubMed Central

14 March 2019

Europe PubMed Central

22 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

2 August 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Molecular and Electrophysiological Mechanisms Underlying Cardiac Arrhythmogenesis in Diabetes Mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Reactive Oxygen Species, Endoplasmic Reticulum Stress and Mitochondrial Dysfunction: The Link with Cardiac Arrhythmogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Inflammation and the pathogenesis of atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Quantitative methods in the review of epidemiologic literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

30 September 2017

Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

29 June 2018

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

29 June 2018

Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5382449

22 September 2018

Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: a review of current evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of pioglitazone on retardation of persistent atrial fibrillation progression in diabetes mellitus patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28381265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12872-017-0531-4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36337187&oldid=2230087712"